Anzeige
Mehr »
Login
Donnerstag, 24.04.2025 Börsentäglich über 12.000 News von 692 internationalen Medien
Jetzt knallt's an der Börse! Diese Aktie hat das Zeug zum Überflieger!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EHBS | ISIN: US17166A1016 | Ticker-Symbol:
NASDAQ
24.04.25
15:32 Uhr
1,930 US-Dollar
+0,040
+2,12 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
CIBUS INC Chart 1 Jahr
5-Tage-Chart
CIBUS INC 5-Tage-Chart

Aktuelle News zur CIBUS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
CIBUS Aktie jetzt für 0€ handeln
15:06Cibus, Inc.: USDA-APHIS Designates Additional Cibus' Disease Resistance Trait Products as Not Regulated2
24.03.Cibus, Inc. - S-8, Securities to be offered to employees in employee benefit plans3
21.03.Cibus outlines advanced gene editing initiatives with potential revenue milestones by 20261
20.03.Cibus GAAP EPS of -$0.87 misses by $0.11, revenue of $1.21M beats by $0.08M1
20.03.Cibus, Inc. - 10-K, Annual Report-
20.03.Cibus, Inc. - 8-K, Current Report-
20.03.Cibus, Inc.: Cibus Reports Fourth Quarter Financial Results and Provides Business Update141A major milestone on March 14th 2025 advanced the EU Trilogue discussions aimed to complete the final text of the New Genomic Techniques (NGTs) or gene editing legislation for the EU; California Rice...
► Artikel lesen
17.03.Cibus, Inc.: Cibus Welcomes the European Union's Progress as Legislation for New Genomic Techniques to Boost Innovation and Sustainability Moves Forward124Legislation aims to adapt EU law to reflect scientific and technological progress, enabling the products of New Genomic Techniques (NGTs), such as gene editing, to contribute to more sustainable agriculture...
► Artikel lesen
04.03.Cibus, Inc.: Cibus' Achieves Another Milestone for a Durable White Mold (Sclerotinia) Resistance Trait in Canola2
28.02.Cibus Names President And COO Peter Beetham Interim CEO As Rory Riggs Resigns-
28.02.Cibus, Inc.: Cibus Announces Leadership Change and CEO Succession Plan160SAN DIEGO, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies...
► Artikel lesen
28.02.Cibus, Inc. - 8-K, Current Report-
19.02.Cibus Capital Supports Sustainable, Tech-Focused Food Merger1
14.02.Cibus, Inc.: Cibus Announces Important Update to Rice Gene Editing Conversion Rates2
22.01.Cibus, Inc. - 8-K, Current Report-
21.01.Cibus secures $22.6 million in registered direct offering4
21.01.Cibus, Inc.: Cibus, Inc. Announces $22.6 Million Registered Direct Offering Priced Above Nasdaq's Minimum Price in Accordance with Nasdaq Rules156SAN DIEGO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company" or "Cibus"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to...
► Artikel lesen
16.01.Cibus, Inc.: Cibus' Agriculture Breeding Breakthroughs Create New Industry Paradigms for Development and Commercialization of Plant Traits2
16.12.24Cibus, Inc.: Cibus, Albaugh LLC and RTDC Company Limited Affirm Collaboration to Enable Commercialization of Cibus' First Gene Edited Weed Management Solution for U.S. Rice Growers1
10.12.24Cibus, Inc. - 8-K, Current Report-
Seite:  Weiter >>
33 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1